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Background: Insight into protein–protein interactions (PPIs) is highly desirable in order to understand the phys-
iology of cellular events. This understanding is one of the challenges in biochemistry andmolecular biology today,
especially for eukaryoticmembrane proteinswhere hurdles of production, puriﬁcation and structural determina-
tion must be passed.
Scope of review:Wehave explored the common strategies used to ﬁndmedically relevant interaction partners of
aquaporins (AQPs). The most frequently used methods to detect direct contact, yeast two-hybrid interaction
assay and co-precipitation, are described together with interactions speciﬁcally found for the selected targets
AQP0, AQP2, AQP4 and AQP5.
Major conclusions: The vast majority of interactions involve the aquaporin C-terminus and the characteristics of
the interaction partners are strikingly diverse.While thewell-establishedmethods for PPIs are robust, a novel ap-
proach like bimolecular ﬂuorescence complementation (BiFC) is attractive for screeningmany conditions as well
as transient interactions. The ultimate goal is structural evaluation of protein complexes in order to get mecha-
nistic insight into how proteins communicate at a molecular level.
General signiﬁcance:What we learn from the human aquaporin ﬁeld in terms of method development and com-
munication between proteins can be of major use for any integral membrane protein of eukaryotic origin. This
article is part of a Special Issue entitled Aquaporins.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
1.1. Protein interactions constitute the fundament for cellular processes
All biological processes involve some kind of communication be-
tween macromolecules in the cellular environment. The identiﬁcation
of cellular interaction partners is fundamental in our understanding of
the processes of life. Nevertheless, the investigation of protein–protein
interaction partners (PPIs) is a relatively young discipline even though
it has been invaluable in the understanding of a variety of key processes
like physical motion, metabolism and signaling cascades [1]. While
there is a great deal of functional and structural information available
for puriﬁed targets, the identiﬁcation and analysis of protein complexes
are still a major challenge.nt protein; ICC, immunocyto-
itation; PPI, protein–protein in-
rins.
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falk).
. Open access under CC BY-NC-ND licensThe scope of this review is to reﬂect on the aquaporin protein inter-
action partners which can shed light on themolecular mechanisms and
physiological roles of this group of integral membrane proteins. We
have focused on four members of the human aquaporin family of pro-
teins: AQP0, AQP2, AQP4 and AQP5. These aquaporins are of medical in-
terest [2] and they are regulated by different means involving transient
or more long-term interactions with other proteins. Human aquaporins
are known to be regulated by gating of membrane localized protein or
by translocation of the protein to themembrane where both phenome-
na involve interactions with other protein partners [3,4] (Fig. 1). Struc-
tural evaluation of co-crystallized complexes of these targets would be
highly desirable to aid our understanding of their physiological role in
the eukaryotic cell. In the literature, there are many reports on putative
interaction partners and quite a variety of methods have been applied
ranging from genomic and proteomic analyses, to structural evaluation
via methods investigating direct physical contact. In this review we
focus on a selection of PPI methods which have been widely applied
in the aquaporin ﬁeld where the direct contact between proteins has
been evaluated. Also, we reﬂect on promising methods for the future
search for a deeper understanding of the physiological role of aqua-
porins in a cellular context. Even though the focus is the human iso-
forms, related eukaryotic proteins are also included in the summary,
giving a more complete picture of PPIs for selected aquaporins. Inde-
pendent of the target of choice, protein–protein interactions is a
broad theme difﬁcult to cover, both with respect to the methodse.
Fig. 1. Aquaporin regulation and translocation. Aquaporins can be regulated by trafﬁcking
(where the protein is moved to/from the plasma membrane via internalization into vesi-
cles) or by gating where structural changes close the water channel.
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been found for a selection of targets applying common methods for
physical interaction. In this respect, this review is unique in its kind pro-
viding an overview of protein–protein interaction studies in general.
2. Methods
Studying PPIs is regarded as a relatively young discipline where
method development and a series of key experiments have led the
way forward [1]. There is a wide range of methods available to track
PPIs which have biophysical, biochemical, computational and genetic
origins allowing detection of direct interactions [5,6]. Worth noting is
that the majority of available methods are developed for soluble pro-
teins and sometimes ﬁne tuned and adapted to suit membrane protein
targets for which they are not necessarily ideal. In addition, many of the
methods have the intrinsic complication to give rise to a high degree of
false hits,where the false positive indications are commonly regarded as
themost complicated part, as described below. As a consequence, there
aremany possible aquaporin interaction partners presented in the liter-
ature as being of importance for channel gating or trafﬁcking to the
membrane where they function. However, due to the tendency of
over-interpretation of positive hits, additional data is commonly needed
to verify a certain PPI. This also relates to the use of methods providing
indirect evidence for interactions, which is even more complicated for
transient interactions which are harder to track. In the scope of this
review we have searched for the methods most frequently used to
provide evidence of physical contact for a certain interaction. We have
focused on interactions documented using the well-established
methods: yeast two-hybrid screening [7], predominantly using soluble
domains, and co-precipitation [8,9]. Interactions identiﬁed by these
methods are commonly also veriﬁed in vivo using microscopy and
immunohistochemistry.
The use of these methods in the search for PPIs with AQP0, AQP2,
AQP4 and AQP5 have been evaluated and the particular methods are
described in more detail below highlighting their strengths and
weaknesses.
2.1. Yeast two-hybrid interaction assay
The identiﬁcation of PPIs has successfully involved protein comple-
mentation assays (PCAs) where a reporter protein is separated into
two fragments and only becomes active upon assembly. Fusing the tar-
get protein pair to either of the fragments and detecting the phenotype
related to a functional reporter protein can be used for many different
reporter systems. The yeast two-hybrid (YTH) system is a geneticmethodthat has been extensively used to study protein interactions [6]. This
method utilizes a reporter gene with a transcription activator having
two modules: one activating domain and one DNA binding domain
that activate transcription creating a phenotype as a result of the pro-
tein interaction [7] (Fig. 2A).
YTH is one of the most commonly used assays in PPI studies and
the design of the YTH constructs is a simple and fairly inexpensive
procedure with the bait protein fused to the binding domain and
the target fused to the activating domain (Fig. 2A). The system recog-
nizes protein interactions in vivo and even weak or transient interac-
tions can be detected [10]. The major disadvantage of the method is
the very high frequency of false positives, up to 50% by some estimates
[11]. Examples of false positive interactions can be proteins directly
binding and activating the reporter gene, non-speciﬁc binding to the
baits and autoinduction by the bait protein independent of the prey
[6]. Only pairs of two interacting proteins, rather than larger complexes,
can be screened using this method. Also, it is possible that the target
protein, when produced in yeast, is lacking posttranslational modiﬁca-
tions necessary for the interaction causing true interactions to remain
undetected resulting in false negatives.
A large variety of modiﬁed YTH systems have been developed over
time to accommodate the need to screenmore difﬁcult targets. Variants
using the tobacco etch virus (TEV) protease [12] and luciferase [13,14]
have been used in mammalian cells as well as in living animals. For
membrane proteins, the option is to use a soluble domain for the
screening or a more indirect version of YTH. The split-ubiquitin method
was developed since the translocation of the membrane proteins into
the nucleus is often unsuccessful [15]. The membrane yeast two-hybrid
system (MYTH) allows full-length membrane proteins to be included
in the assay, rather than limiting the screen to soluble domains of the
protein. Ubiquitin can be used for protein fragment complementation,
where it is divided into two non-functional fragments that regain func-
tion when re-associated [16]. Linking the N- and C-terminal parts of
ubiquitin to the bait and prey proteins, respectively, will result in cleav-
age of an attached transcription factor upon interaction. The transcrip-
tion factor is transported into the nucleus and the readout of the assay
is possible by the same means as for the traditional YTH. This method
has successfully been used for the identiﬁcation formore than 100 inte-
gralmembrane proteins in Saccharomyces cerevisiae [17].More recently,
a method for high-throughput screening of PPIs inmammalian cells has
been developed allowing detection in a cell array format [18]. Adherent
cells are transfected with plasmids encoding the bait protein, the prey
protein and an auto-ﬂuorescent reporter protein. Interaction between
the target proteins leads to transcription of the reporter gene and the
ﬂuorescence output can be read out using DNA array scanners. This is
a ﬂexible and promisingmethod for studies of PPIs in a variety of mam-
malian cell lines with high efﬁciency [18].2.2. Pull-down and co-immunoprecipitation
Thepull-down aswell as the co-immunoprecipitation assay are used
to detect interaction partners with the protein of interest from cell ly-
sate. Thesemethods allow pulling your target protein out of the homog-
enate together with the putative interaction partners. The advantage
compared to a puriﬁed protein in a buffer, the milieu of the proteins in
the cell lysate is close to native. The PPI is not detected in vivo which
makes it necessary to conﬁrm whether the two proteins are co-
localized in the native cell. Both assays are often used in combination
with immunostaining (Table 1).
The pull-down assay is a PPI assay where the protein of interest is
taggedwith e.g., Glutathione S-transferase (GST) or biotin which allows
it to be immobilized to a tag-speciﬁc afﬁnity resin (Fig. 2B). This modi-
ﬁed resin is incubated with the cell lysate and interacting proteins are
indirectly bound to the resin. The entire protein complex is eluted by
adding competitive compounds or changing pH or salt concentration,
Fig. 2.Methodsused to studyaquaporins (listed in Table 1) (A)Yeast two-hybrid interaction assay. The transcription activator is divided into two fragments, one activating domain (AD) and
one DNA binding domain (DBD). Upon interaction of the two proteins (blue) the function of the transcription activator is restored and the reporter gene can be expressed. The gene prod-
uct gives rise to a phenotype that can be used as a read out of the protein interaction. (B) Pull-down assaywhere the bait protein is linked to agarose beads and (C) co-immunoprecipitation
where an antibody against the target protein is used.
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considered in each speciﬁc case.
For isolation of interaction partners to untagged proteins, immuno-
assays have been successful. Co-immunoprecipitation is a widely used
method with extensive examples in the literature [5]. This assay is in
many respects similar to the pull-down assay, butwith the use of an an-
tibody linked to the resin rather than the bait protein [9]. The use of an-
tibodies also introduces new aspects to the detection and increases the
need for validation of the hits, since the antibodies can vary in speciﬁcity
and thewashes affect the stringency of the analysis [19]. Two variants of
the different immunoprecipitation methods [9] are highlighted in this
review.
The classical immunoprecipitation uses an antibody, either mono-
or polyclonal, synthesized to recognize a speciﬁc protein (Fig. 2C).
The antibody is mixedwith the cell lysate to form the antibody–protein
complex. The target protein and its presumed interaction partner bind
to the antibody. Subsequently, the sample is incubated with a general
antibody binding resin — usually agarose beads with either protein
A or G bound depending on the antibody used. The ﬁnal result is a
protein–antibody complex that is eluted from the resin. Worth not-
ing, this complex includes the antibody which can hinder further
downstream protein analyses (Fig. 2C). Further, cross-linkers can
be combined with the protein A beads to orient the antibody com-
plex binding to the resin. The antibody interaction with the beads
will, as for the traditional method, be efﬁcient since the epitope bind-
ing regions of the antibody are directed away from the beads,
enabling efﬁcient binding. Also, if the antibody is bound to the pro-
tein A beads using cross-linkers, antibody contamination upon pro-
tein elution is prevented. Some caution is advised, however, since
potential cross-linkers react with amines which could interfere
with the interaction at the protein–antibody interface. A titration of
cross-linker concentration should therefore always be performed.
Direct immunoprecipitation prevents the antibody from contaminat-
ing the ﬁnal protein sample by binding the antibody directly to the
resin. This can be of great use when using an antibodywith lower afﬁn-
ity for protein A or G. Due to a random interaction between the antibody
and the resin the accessibility of the protein-interacting domains of the
antibody is decreased.2.3. Immunostaining
Immunostaining is a collective termwhich encompasses both immu-
nohistochemistry (IHC) and immunocytochemistry (ICC). These are both
methods where antibodies conjugated with a visible molecule are
used to determine the localization of the protein of interest in situ
(reviewed in [20]). IHC and ICC are often used without distinction
even though IHC is observed in the protein localization in whole tissues
while ICC is performed on cells separated from the extra cellular matrix
that can be obtained from any suspension of cells [20]. The ease with
which the antigen (protein) is detected by the labeled antibody is deter-
mined by three major factors: the local antigen concentration, the ac-
cessibility of the antibody epitope and the speciﬁcity of the antibody
used. The sample preparation is also an important factor for a successful
immunostaining and thismost often involvesﬁxation of the cells by var-
ious methods [22]. Moreover, the ﬁxation procedure itself may change
the pattern of recognition between the antibody and the antigen
which can give rise to false positive as well as false negative signals,
where cross-reaction, or unspeciﬁc interactions, between the antibody
and the cellular antigens may be a major contributor to background
noise. In addition, the resolution and sensitivity of the staining are af-
fected by the method used for detection [21]. Taking all above aspects
into account, immunostaining requires an arsenal of controls ranging
from veriﬁcation of the antibody to analyses of cell lines lacking the an-
tigen [21].
3. Results
3.1. AQP0
AQP0 is the dominating protein in the ﬁber cells of the eye lens
[23] where its function as a water channel is required for homeosta-
sis and transparency of the lens [24]. The water transport via AQP0 is
regulated by three different means: C-terminal cleavage [25], pH and
Ca2+/calmodulin (CaM) [26]. Besides being a channel for water,
AQP0 is involved in the formation of gap junctions which are pores
allowing molecules b1 kDa to be transported between the cells in
the lens. The junctions are formed by interactions between AQP0
Table 1
Proteins found to directly interact with AQP0, AQP2, AQP4 and AQP5 using the yeast two-hybrid interaction assay or co-precipitation.
Target Interacting protein Proposed function Method applied Ref
YTH PD IP IHC MS
cAQP0 Cx45.6, Cx56 Formation of gap junction during lens development xa x x [31]
mAQP0 Crystallin Structural organization in lens ﬁbers xa x [32]
hAQP0 Filensin Maintain lens ﬁber cell shape and organization xa x x x [33]
hAQP0 CP49 Maintain lens ﬁber cell shape and organization xa x x x [33]
bAQP0 ezrin Fiber cell morphology, elongation and organization xa x x [34]
sAQP0 AKAP2 Preserve lens transparency x x
hAQP2 LIP5 Lysosomal degradation xa xa x x [45]
hAQP2 Caveolin-1 AQP2 internalization x xb [47]
hAQP2 MAL Increase apical surface expression x x [48]
rAQP2 Spa1 Regulates trafﬁcking to the apical membrane xa x x x [49,50]
rAQP2 hsc70 Co-localized in the apical membrane: involved in trafﬁcking xa,c x x x [51]
hAQP2 AKAP220 Phosphorylation of AQP2 triggering trafﬁcking xd xe [52]
rAQP2 Annexin II Phosphorylation dependent binding to the C-terminus xd x x [53]
rAQP2 PP1c Phosphorylation dependent binding to the C-terminus xd x x [53]
rAQP2 BiP Phosphorylation dependent binding to the C-terminus xd x x x [53]
hAQP2 hAQP5 Impairing AQP2 membrane localization x x [54]
rAQP4 μ-AP3 Lysosomal targeting and degradation xa x [67]
rAQP4 DGC Localization to facilitate K+ buffering x x [68,69]
rAQP4 Na, K-ATPase Water and K+ homeostasis and neuron–astrocyte interaction x xb [70]
rAQP4 mGluR5 Water and K+ homeostasis and neuron–astrocyte interaction x [70]
mAQP5 PIP Binding to the C-terminus for transportation to the membrane x x x [83]
YTH, yeast two-hybrid interaction assay: PD, pull-down: IP: immunoprecipitation: IHC, immunohistochemistry: MS, mass-spectrometry.
a Using C-terminal region of the aquaporin.
b Immunocytochemistry.
c Using human kidney cDNA library.
d Full-length protein is used.
e Rat kidney.
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terminal modiﬁcations [27]. Further, a PKC dependent phosphoryla-
tion event at Ser236 is suggested to be involved in the translocation
of AQP0 to the plasma membrane, as studied by mutational analysis
and immunoﬂuorescence confocal microscopy [28]. Patient studies
have revealed several mutations in AQP0 that can lead to congenital
cataracts [29,30].
Proteins found to directly communicate with AQP0 are part of the
structural compartments of the cell demonstrating an important role
for this aquaporin in the membrane structure of the eye lens (Fig. 3).
AQP0 co-localizes with the gap junction forming protein connexin, as
shown by SDS-fracture immune labeling [60]. Its proposed role in
clustering and gathering of gap junctions during lens development is
further supported by immunoprecipitation and immunohistochemistry
studies in which AQP0 interacts and co-localizes with two connexins
(Cx45.6 and Cx56). The interaction between these connexins and the
AQP0 C-terminus was veriﬁed by pull-down experiments [31]. From a
yeast two-hybrid screen using the C-terminal 74 amino acids of AQP0
as bait, interaction with γE-Crystallin, speciﬁcally expressed in lens
ﬁbers, was identiﬁed as a binding partner. The interaction with full-
length AQP0 was conﬁrmed by co-immunoprecipitation [32]. Addition-
al support for the importance of AQP0 in the maintenance of the lens
ﬁber cell shape and organization is the proposed interaction with the
intermediate ﬁlaments ﬁlensin and CP49 (ﬁlament-like proteins in the
ocular lens) as found with afﬁnity puriﬁcation using either the AQP0
C-terminus in a pull-down experiment or an AQP0 antibody in immuno-
precipitation. The co-localization at the plasma membrane was veriﬁed
with immunoﬂuorescence confocal microscopy and immunoelectron
microscopy [33]. In addition, chemical cross-linking followed by mass-
spectrometry analysis revealed interaction between the AQP0 C-
terminus and proteins involved in linking the actin ﬁlaments to the
plasma membrane. Speciﬁcally, co-immunoprecipitation and pull-down
experiments have shown interaction between the AQP0 C-terminus
and ezrin which could play a role in ﬁber cell morphology, elongation,
and organization [34]. Interestingly, A-kinase anchoring protein 2
(AKAP2) forms a stable complexwith AQP0 allowing PKA phosphoryla-
tion of Ser235 preserving lens transparency. The interaction betweensheep AQP0 and AKAP2 was identiﬁed by immunoprecipitation and
conﬁrmed by immunohistochemistry on mouse lenses [35].
3.2. AQP2
AQP2 is a water channel in the kidney where it is responsible for
the concentration of urine. The protein is located in the principal
cells of the collecting duct and its translocation to the apical mem-
brane is dependent on the binding of the hormone vasopressin to
the V2 receptor [36] where vasopressin increases the water perme-
ability by inducing the reversible translocation of AQP2 to the apical
membrane [37]. Regulation by trafﬁcking is suggested for a few
aquaporins but is best characterized for AQP2 [38]. In principle,
there are two possible routes for AQP2 translocation: either AQP2
is trafﬁcked to the apical membrane upon phosphorylation and vaso-
pressin binding to the V2 receptor, or it is targeted for lysosomal degra-
dation upon ubiquitination. Translocation of AQP2 is regulated by the
channel itself involving phosphorylation of Ser256, as analyzed by mu-
tational analysis, surface expression and in vivo phosphorylation [39].
Inhibitor studies combined with mutational analysis demonstrate that
protein kinase A is possibly involved in the vasopressin-induced traf-
ﬁcking of AQP2 [40]. Additional mutational analysis concludes that
phosphorylation of Ser256 is necessary and sufﬁcient for expression of
AQP2 in the apical membrane [41]. Phosphorylation of the C-terminus
regulates AQP2 by trafﬁcking and not gating, as showed by mutational
analysis of putative C-terminal phosphorylation sites assayed in the oo-
cyte system [42]. Internalization of AQP2 involves ubiquitination of
Lys270 at the C-terminus, which enhances endocytosis and targets
AQP2 tomultivesicular bodies (MVBs) for subsequent lysosomal degra-
dation [43]. Incorrect translocation or function of AQP2 gives rise to
nephrogenic diabetes insipidus (NDI) resulting in an excess of excreted
urine, polyuria.When caused bymutations in AQP2, those are either lo-
cated in the C-terminus of the protein interferingwith the translocation
to the apical membrane or in the pore-forming-region giving rise to a
misfolded protein [44].
The regulation by trafﬁcking is well studied and understood for
AQP2 and, not surprisingly, all of the identiﬁed interaction partners in
Fig. 3. Proteins interacting with AQP0, AQP2, AQP4 and AQP5. Aquaporin interaction partners involved in translocation, gating or cellular structure are indicated, aswell as the location for
the binding in those cases it has been determined. Binding partners to different aquaporins are indicated in different colors and those binding to the human isoform aremarkedwith a red
outline.
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(Fig. 3). Many proteins are found to communicate with AQP2 during
the phosphorylation and translocation to the apical membrane. One
interacting protein has been found to be part of the lysosomal degrada-
tion route of AQP2: lysosomal trafﬁcking regulator interacting protein 5
(LIP5) involved in multivesicular body (MVB) formation. The binding
of LIP5 to the AQP2 C-terminus facilitates its lysosomal degradation
and is independent of Ser256 phosphorylation as well as Lys270
ubiquitination [45]. LIP5 is abundantly expressed in the collecting duct
[46] and has been found to interact with hAQP2 C-terminus in a yeast
two-hybrid screen supported by pull-down assays, immunoprecipita-
tion and immunohistochemistry [45].
Interestingly, the internalization of AQP2 is suggested to take place
via membrane micro-domain related pathways involving binding to
caveolin-1, at least in MDCK cells, as shown by co-immunoprecipitation
supported by double-immunoﬂuorescence microscopy [47]. Further, the
myelin and lymphocyte-associated protein (MAL) attenuates the internali-
zation of AQP2 by increasing the trafﬁcking of the water channel to the
apical surface. MAL interactsmore strongly to the Ser256 phosphorylated
formof the protein, as veriﬁedwith immunoprecipitation and immuno-
histochemistry in combination with mutational analysis [48]. From
pull-down experiments the human AQP2 C-terminus has been found
to interact with signal-induced proliferation-associated gene-1 (SPA-1)
[49]. Immunoprecipitation and immunohistochemistry experiments
combinedwithmass-spectrometry [50] further support the direct bind-
ing of SPA-1 to rat AQP2, an interaction suggested to regulate the AQP2
trafﬁcking to the apical membrane [49]. Another example of a direct in-
teraction being of importance for the AQP2 trafﬁcking is the co-
localization of the 70-kDa heat shock protein hcs70 in the apical mem-
brane of rat kidney cells. This binding partner was found in a yeast
two-hybrid screen using soluble domains of rat AQP2 as bait. Theinteraction between the hcs70 and the C-terminus of rat AQP2 was fur-
ther supported by in vitro studies using pull-down experiments where
Ser256 was shown to be important for the interaction [51]. Moreover,
in a yeast two-hybrid screen, using full-length human AQP2 as bait
and the split ubiquitin approach, the A-kinase anchoring protein
(AKAP220) was found to bind AQP2 with the proposed function to re-
cruit protein kinase A for the phosphorylation event and thereby have
a positive inﬂuence on the trafﬁcking [52].
Binding partners of phosphorylated versus non-phosphorylated
forms of the AQP2 C-terminus have been evaluated and conﬁrmed by
co-immunoprecipitation of native AQP2. These binding partners are
suggested to be involved in AQP2 trafﬁcking where binding immuno-
globulin protein (BiP) showed a preferred binding to the phosphorylated
C-terminus while annexin II and protein phosphatase 1 catalytic subunit
(PPIc) bind the unphosphorylated state to a higher degree [53].
Interestingly a recently published study showed that aquaporins
bind and regulate other aquaporins. In mice with polyuria, AQP5 was
upregulated and co-localized with AQP2, where a direct interaction
was veriﬁed by immunoprecipitation and further supported by co-
localization in kidney biopsies from patients with nephrogenic diabetes.
AQP5 is therefore suggested to be a binding partner and regulator of
AQP2 impairing its membrane localization [54].
3.3. AQP4
AQP4 is expressed in the brain, lung and kidney and it is the predom-
inant aquaporin in the central nervous system [55]. In astrocytes,
aquaporin-facilitated water ﬂow is beneﬁcial under normal conditions
and required for optimal buffering of the extracellular potassium con-
centration [56]. Both short-term regulation and trafﬁcking have been
reported for AQP4. Phosphorylation is suggested to mediate a short-
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cytosolic serine residues (Ser111 and Ser180) provide putative phos-
phorylation sites (reviewed in [57]). Recent studies, supported bymuta-
tional analysis andmolecular dynamic simulations, indicate that Ser111
is not phosphorylated in vivo and, hence, not responsible for the gating
of AQP4 [58]. On the contrary, phosphorylation inﬂuences the internal-
ization of AQP4 where phosphorylation of the AQP4 C-terminus by pro-
tein kinase C (PKC) is required for Golgi transition [59]. In addition,
translocation of AQP4 is suggested to involve histamine exposure [60]
or a functional interaction to the vasopressin receptor [61]. Still, the
AQP4 translocation appears to occur at a much slower pace than the
trafﬁcking of AQP2 [60]. Other interaction partners, such as Kir4.1,
have been suggested for AQP4which show a similar pattern of subcellu-
lar distribution in astrocytes [62], but there is probably no direct inter-
action between Kir4.1 and AQP4 [57]. A putative role for AQP4 in
cytoskeleton changes has been suggested involving interactions with
connexin 43 [63] and F-actin [64], but direct evidence is lacking in
these cases.Water channels in the brain facilitate brain swelling causing
brain edema, a common complication associated with infections,
hyponatremia, ischemia and trauma [65], leading to severe damage of
the brain. In addition, AQP4 facilitates glial cell migration inﬂuencing
scar formation [66] aswell as having an unexpected role in neural signal
transduction via a yet unknownmechanism [2]. Hence, the AQP4 activ-
ity is of importance in osmotic imbalances in the brain and is therefore a
potential drug target for treatment of not only primarily cerebral
edema, but also cancer and neurological diseases.
For the AQP4 homologue, veriﬁed interaction partners are either re-
lated to trafﬁcking of the water channel or cellular structure (Fig. 3). As
conﬁrmed by yeast two-hybrid interaction assay and immunoprecipita-
tion, lysosomal targeting involves interactions between the AQP4 C-
terminus and the μ subunit of the AP2 clathrin-adapter complex where
endocytosis from the plasma membrane involves AP2 and AP3 is occu-
pied in lysosomal targeting. This interaction is modulated by phosphor-
ylation and points towards a unique C-terminal sorting cassette of
AQP4 [67]. The interaction of AQP4 with the multiprotein dystrophin–
glycoprotein complex (DGC) connecting the cytoskeleton was found by
co-immunoprecipitation and immunohistochemistry. This co-localiza-
tionmight play a role in the buffering of potassium ions [68,69]. Finally,
AQP4 may have a physiological role in the formation of microdomains
in astrocytes which are of importance for water and potassium ion ho-
meostasis as well as for neuron–astrocyte metabolic crosstalk. In this
context, an interaction between AQP4 and the Na,K-ATPase or the
metabotropic glutamate receptor (mGluR5) is suggested. Co-precipitation
and immunocytochemistry applying ﬂuorescence resonance energy
transfer (FRET) have been used to conﬁrm the interaction with Na,K-
ATPase in intact cells and N-terminal key residues of AQP4 (Lys27 and
Trp30) are identiﬁed for the actual interaction [70].
3.4. AQP5
AQP5 is located in sweat glands, lungs, airways and secretory glands
where it plays an important role in the generation of saliva, tears and
pulmonary secretions [71,72]. Trafﬁcking by phosphorylation is sug-
gested based on a mutational study on the 152SRRTS motif in the AQP5
C-terminus where dephosphorylation of the consensus sequence in-
creases GFP-AQP5 translocation and where microtubules, but not mi-
croﬁlaments, are involved in this event [73]. AQP5 can be directly
phosphorylated at two consensus PKA sites: Ser156 and Thr259, in the
cytoplasmic D loop and the C-terminus, respectively. However, alanine
mutants at these positions give rise towild-type characteristics suggest-
ing that cAMP dependent phosphorylation at these sites is not a deter-
minant for AQP5 trafﬁcking [74,75]. For the AQP5 trafﬁcking to the
plasma membrane, increased intracellular Ca2+ is suggested to trigger
this mode of regulation [76]. By triggering the release of Ca2+, adrena-
line induces trafﬁcking of AQP5 to the plasma membrane in rat parotid
cells [77]. In addition, lipopolysaccharide (LPS) and vasoactive intestinalpolypeptide (VIP) both increase the AQP5 content in the plasma and
apical membranes, respectively [78,79]. Regulation by gating has not
been proposed for AQP5 since phosphorylation does not affect the
water permeability of the channel [80]. However, a gating mechanism
has recently been presented where molecular dynamic simulations re-
veal open and closed conformations involving His67 and His173 [81].
AQP5 with impaired function or trafﬁcking has been correlated with
several diseases and disorders such as bronchitis, cystic ﬁbrosis [72]
and Sjögren's syndrome [82].
For the AQP5 homologue, only one protein is found to be directly
bound: prolactin-inducible protein (PIP) (Fig. 3). The binding of PIP to
the AQP5 C-terminus is suggested to normalize AQP5 trafﬁcking to the
apicalmembrane. The interactionwas analyzed using homogenized lac-
rimal glands from mouse delivered into an afﬁnity column bound to
synthetic AQP5 C-terminal peptide and elutes analyzed by electropho-
resis and LC-MS/MS [83].
4. Discussion
4.1. Common themes for aquaporin interaction partners
Themain aim of this review is to give an overview of the research in-
volving the search for aquaporin PPIs. This turned out to be non-trivial
since related methods are often given various names and common
themes are not easily identiﬁed. Table 1 summarizes interacting proteins
to AQP0, AQP2, AQP4 and AQP5 identiﬁed by yeast two-hybrid interac-
tion assay, pull-down assay and co-immunoprecipitation, respectively,
giving that those proteins communicate directly with the aquaporin.
When using these direct methods, immunostaining is usually used to
verify the interaction in cells (ICC) or tissues (IHC), where the latter is
more frequently used (Table 1). Mass-spectrometry, on the other hand,
is often used in a proteomic approach applying afﬁnity puriﬁcation
(using an aquaporin speciﬁc antibody or the aquaporin C-terminus) or
cross-linkingwhich is subsequently veriﬁed by the direct methodsmen-
tioned above.
When comparing the results for AQP0, AQP2, AQP4 and AQP5, some-
what surprisingly, a diverse array of proteins is found to bind. The most
striking common denominator is that the vast majority of directly
interacting proteins are binding to the C-terminal tail of the aquaporins
(Fig. 3). This observation deserves some reﬂection on themethods used
which frequently exclude the membrane-spanning domains. Thus,
novel methods also including the hydrophobic segments could possibly
reveal PPIs having novel characteristics. Moreover, except for CaM, the
PPIs illustrated in Fig. 3 inﬂuence the translocation, trafﬁcking/internal-
ization or lysosomal degradation, of the aquaporins or the cellular struc-
ture. Proteins inﬂuencing the aquaporin channel gating by direct
interaction remain to be explored. Linked to this notion, the aquaporins
in focus here are all suggested to be regulated byphosphorylation,while
only three such binding partners are yet identiﬁed: AKAP2 binds to
AQP0 with importance for the cellular structure [35] and AKAP220
[52] as well as PP1c [53] are involved in trafﬁcking of AQP2 (Table 1).
Even though A-kinase anchoring protein has been identiﬁed as binding
partner for both AQP0 and AQP2, its regulatory role seems to be differ-
ent in these two cases (Fig. 3) illustrating the multiple functions found
for the aquaporin PPIs.
4.2. Protein complementation assays offer progress in the search for novel
PPIs
Typical methods in the PPI ﬁeld include rather time consuming
techniques such as yeast two-hybrid, co-puriﬁcation and co-
immunoprecipitation as described in more detail in this review.
While those methods are known to provide important hints, they
are often labor intensive and give rise to a high number of false iden-
tiﬁcations requiring additional methods for veriﬁcation [84]. An
interesting alternative to the more traditional methods used to
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tions. If well designed, this method allowsmany conditions to be tested
simultaneously in a multi-well format. Notably, ﬂuorescence-based ap-
proaches are also suitable for studying interactions within the plasma
membrane pointing towards their importance in future studies of PPIs
including integral membrane protein targets [85]. Some of the PPIs in
Table 1 have also been analyzed by ﬂuorescence: confocal FRETmicros-
copy has been applied to show the presence of measurable interactions
between AQP0 and crystallins [86] as well as to conﬁrm AQP4 interac-
tion with Na,K-ATPase in intact cells [70]. FRET is based on two full
length ﬂuorophores with overlapping excitation/emission spectra. CFP
and YFP is a common FRET pair where the energy is transferred from
CFP to YFP. By exciting CFP and monitoring the ﬂuorescence of YFP,
the ﬂuorophores can be concluded to be close to each other (10–
100 Å) [87] (Fig. 4A).
Bimolecular ﬂuorescence complementation (BiFC) provides an at-
tractivemethodwhere engineered variants of green ﬂuorescent protein
(GFP) can be used to detect interactions in various organisms (Fig. 4B).
BiFC relies on the fact that e.g. YFP or GFP can be split genetically into
non-ﬂuorescent fragments and reassembled post-translationally to
produce an intact ﬂuorophore indistinguishable from the wild type
protein [88]. The two halves of YFP have low afﬁnity towards each
other, but re-association is greatly enhanced if the fragments are
fused to two proteins that interact strongly together. The great
potential of BiFC is the possibility to detect short term interactions
in addition to more stable complexes. Since the re-association of
the YFP halves in principle is irreversible, transiently interacting
proteins can be trapped [89]. Thereby, BiFC could possibly enableFig. 4. Potential applications in the aquaporin ﬁeld. (A) The FRET assay. If the proteins are in close
BiFC assay. Interacting proteins are fused to two parts of YFP, both of which are non-ﬂuorescendetection of PPIs being part of phosphorylation events which are fre-
quently involved in protein regulation.
BiFC was used to investigate heterotetramerization of Arabidopsis
thaliana aquaporin isoforms in S. cerevisiae [90]. The authors show
how different isoforms of tonoplast intrinsic proteins (TIPs) form
ﬂuorescent complexes when fused to complementary fragments of
the venus YFP variant. This method can prove to be of great use
also in screening for new interacting partners by using the diploid
phase of S. cerevisiae. The two protein libraries can be transformed
to strains with opposite mating types and the subsequent ﬂuores-
cence readout can be used to identify protein interaction partners
[91]. A great deal of knowledge has been obtained over the last de-
cade and input on experimental planning has been reviewed by
Kodama and Hu [88].
BiFC is a promising method to apply also for the human AQPs, since
for a variety of protein targets, protein complementation assays have
been very successful in the ﬁndings of PPIs. The strategywhere an active
protein is cut in two non-active fragments that are “re-activated” upon
reassembly is central in both the YTH and the BiFC. Luciferase and
dihydrofolate reductase (DHFR) have also been successfully used in
the PPI ﬁeld [13,92]. A modiﬁed dihydrofolate reductase (DHFR) PCA
assay presented by Tarassov et al., based on survival of cells in the pres-
ence of an inhibitor forwild type DHFR, has been used for genome-wide
screening of interactions in S. cerevisiae [92]. The DHFR PCA has the ad-
vantage of monitoring cell proliferation as the phenotypic result of a PPI
and the interaction can take place in the cytoplasm rather than the nu-
cleus, further removing an obstacle for proteins that normally do not lo-
calize to this cellular organelle [93].proximity to each other, emitted light from excited CFPwill cause YFP to ﬂuoresce. (B) The
t. When in close proximity the YFP fragments assemble and give rise to ﬂuorescence.
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When available, structural information is superior in the search for a
deeper understanding of the nature of the interaction within a protein
or between two proteins. When combined with biochemical data, the
molecular mechanism can be unraveled, as exempliﬁed by the interac-
tion between AQP0 and calmodulin (CaM). This PPI has been analyzed
by NMR and pull-down assays showing that CaM binds to the AQP0 C-
terminus in a calcium-dependent manner where two CaM molecules
bind to the AQP0 tetramer [94]. The structural model based on these
ﬁndings suggests that the binding of CaM inhibits the permeation of
water through the channel, where the actual binding of CaM is regulat-
ed by phosphorylation of the C-terminus of AQP0 [95]. Further, co-
operativity between adjacent subunits was recently suggested to be in-
volved in the closure of the cytoplasmic gate of AQP0 upon CaMbinding
[96].
Given that the majority of the PPIs interact with the hydrophilic ex-
tensions of the aquaporins (Fig. 3), it is ofmajor interest to include these
in structural analyses. However, when applying crystallized protein and
X-ray for the structural analysis, one limitation is often to include ﬂexi-
ble regions in the crystal formation and hydrophilic extensions are com-
monly excluded already in the design of the recombinant protein [97].
Nevertheless, the future vision for aquaporin PPIs is in the development
of methods allowing high-resolution structures of protein complexes to
be obtained that reveal the molecular signals controlling gating or traf-
ﬁcking of speciﬁc targets. For this purpose, the BiFC could be used in the
screen for novel interaction partners which could subsequently be con-
ﬁrmedbymicroscopy [98]. The additional beneﬁt using the YFP fusion is
that it could potentially be advantageous in the stabilization of the pro-
tein complexes making them more amendable for crystallization [99].
Ideally, while YFP aids stable complex formation, the binding of PPI
could stabilize the termini allowing inclusion of those in the ﬁnal struc-
ture. Improved methods leading to high-resolution structures of aqua-
porin:protein complexes would provide desirable and novel insight
into the physiological role of aquaporins where communication with
other proteins belongs to the key processes in the cell.
5. Conclusions
In general, screeningmethods for PPIs are non-optimal due to many
false positives. Thus, independent of which screening method you de-
cide to use, proper controls are of major importance. Moreover, struc-
tural evaluation, when possible, is superior in order to achieve a
deeper understanding of a certain PPI. In the search for novel aquaporin
PPIs it is interesting to see that aquaporins regulate other aquaporins
[54], mechanisms that could be of pronounced importance in tissues
where multiple isoforms are produced [2]. In addition, more integral
membrane proteins are available in their pure form allowing more in-
teraction partners to be detected, as shown for the GPCR family of pro-
teins [100]. In light of this notion, it is promising to conclude that the
majority of the human aquaporin isoforms can be produced with
high-yields in their functional form in the Pichia pastoris host system
[101] allowing further studies of their physiological roles and possible
interactions with other cellular targets.
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